Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BI-4732 |
Synonyms | |
Therapy Description |
BI-732 is a fourth-generation EGFR inhibitor with activity against C797S, which potentially decreases tumor growth (Cancer Res (2023) 83 (7_Supplement): 4476). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
BI-4732 | BI 4732|BI4732|BI-732|BI 732|BI732 | EGFR Inhibitor 4th gen 16 | BI-732 is a fourth-generation EGFR inhibitor with activity against C797S, which potentially decreases tumor growth (PMID: 38330145). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|